Prof. Ismail YALCIN, Ph.D.

Tel : +90 (312) 223 92 53

Educational and Administrative Background

1976: B.Sc., Gazi University, Faculty of Pharmacy
1983: Ph.D. degree at Ankara University Faculty of Pharmacy Department of Pharmaceutical Chemistry
1986: Assistant Professor at Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry
1987: Associate Professor Degree at Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry
1993-Present: Full Professor at Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry
2002-2005: Ankara University, Faculty of Pharmacy, Head of the Department of Pharmaceutical Chemistry
2003-2007: President of the Computer Aided Drug Design and Development Society in Turkey
2006-2008: President of the Asian Federation for Medicinal Chemistry (AFMC)
2008-2012: Assistant to the President of Ankara University

Language Background

  •  Turkish (Native Language)
  •  English (Fluent)

Doctoral Theses Supervised

  • Two Ph. D. Thesis Supervised and completed.

Master Theses Supervised

  • Six Master Thesis Supervised and completed.

Editorial Board Memberships

  • Guest Editor of the Journal of QSAR & Combinatory Sciences in 2005

Symposium and Meeting Organizations

  • Co-Chair of the “15th European Symposium on Quantitative Structure-Activity Relationships”, Istanbul, 05-10 September 2004.
  •  Member of the Organizing Committee of the "Workshop on Computer Aided Drug Design & Development", Istanbul-TURKEY, February 02-05, 2007.
  •  Chairman of the “6th International Medicinal Chemistry Symposium of Asian Federation for Medicinal Chemistry (AFMC)", Istanbul-TURKEY, July 01-04, 2007.

Memberships

  • International QSAR and Modelling Society
  •  American Chemical Society
  •  Computer Aided Drug Design and Development Society (CADD&D Society) in Turkey

Original Papers

  • 81
    AKI-YALCIN, E., ERTAN-BOLELLI, T., TASKIN-TOK, T., OZTURK, O., ATAEI, S., OZEN, C., YILDIZ, I., YALCIN, I., "Evaluation of Inhibitory Effects of Benzothiazole and 3-Amino-benzothiazolium Derivatives on DNA Topoisomerase II by Molecular Modeling Studies", SAR and QSAR in Environmental Research, 25(8), 637-649, (2014). doi:10.1080/1062936X.2014.923039 [full text]
  • 80
    ERTAN-BOLELLI, T., MUSDAL, Y., BOLELLI, K., YILMAZ, S., AKSOY, Y., YILDIZ, I., AKI-YALCIN, E., YALCIN, I., “Synthesis, Biological Evaluation of 2-Substituted-5-(4-nitrophenylsulfonamido) benzoxazoles as Human GST P1-1 Inhibitors and Description of the Binding Site Features”, ChemMedChem,9(5), 984-992, (2014). doi:10.1002/cmdc.201400010 [full text]
  • 79
    YILMAZ, S., ALTINKANAT-GELMEZ, G., BOLELLI, K., GUNESER-MERDAN, D., OVER-HASDEMIR, M. U., YILDIZ, I., AKI-YALCIN, E., YALCIN, I., “Pharmacophore Generation of 2-Substituted Benzothiazoles as AdeABC Efflux Pump Inhibitors in A. baumannii”, SAR and QSAR in Environmental Research, 25(7), 551-563, (2014). doi:10.1080/1062936X.2014.919357 [full text]
  • 78
    UNSALAN, O., SERT, Y., ARI, H., SIMÃO, A., YILMAZ, A., BOYUKATA, M., BOLUKBASI, O., BOLELLI, K., YALCIN, I., “Micro-Raman, Mid-IR, Far-IR and DFT studies on 2-[4-(4-Fluorobenzamido)phenyl]benzothiazole”, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 125, 414-421, (2014). doi:10.1016/j.saa.2014.01.118 [full text]
  • 77
    ZILIFDAR, F., ALPER-HAYTA, S., YILMAZ, S., KAPLAN-OZEN, C., FOTO, E., AYDOGAN, Z., YILDIZ, I., AKI, E., YALCIN, I., DIRIL, N., "Genotoxic potentials and eukaryotic DNA topoisomerase I inhibitory effects of some benzoxazine derivatives", Med. Chem. Res., 23(1), 480-486, (2014). [full text]
  • 76
    YILMAZ, S., YALCIN, I., KAYNAK-ONURDAG, F., OZGEN, S., YILDIZ, I., and AKI, E., "Synthesis and In vitro Antimicrobial Activity of Novel 2-(4-(Substituted-carboxamido)benzyl / phenyl)benzothiazoles", Croat. Chem. Acta, 86(2), 223-231, (2013). [full text]
  • 75
    KAPLAN-OZEN, C., TEKINER-GULBAS, B., FOTO, E., YILDIZ, I., DIRIL, N., AKI, E., YALCIN, I., "Benzothiazole derivatives as human DNA topoizomerase IIα inhibitors", Med. Chem. Res., 22(12), 5798-5808, (2013). [full text]
  • 74
    BOLELLI, K., YALCIN, I., ERTAN-BOLELLI, T., OZGEN, S., KAYNAK-ONURDAG, F., YILDIZ, I, AKI, E., "Synthesis of novel 2-[4-(4-substitutedbenzamido/phenylacetamido)phenyl]benzothiazoles as antimicrobial agents", Med. Chem. Res., 21, 3818-3825, (2012). [full text]
  • 73
    TASKIN, T., YILMAZ, S., YILDIZ, I., YALCIN, I., AKI, E., "Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cell lines by molecular docking", SAR and QSAR Environmental Research, 23(3-4), 345-355, (2012). [full text]
  • 72
    AKI, E., YALCIN, I., YILDIZ, I., TEMIZ-ARPACI, O., BOLELLI, K., ERTAN-BOLELLI, T., DNA-Topoisomerase Inhibitory Activity of Some Heterocyclic Compounds and Their Structure-Activity Relationships", Med. Chem. Res., 19, S6, (2010). [full text]
  • 71
    YALCIN, I., AKI, E., YILDIZ, I., TEMIZ-ARPACI, O., "Antimicrobial Activity and Structure–Activity Relationships of Some Synthesized Benzazoles and their Possible Metabolites", Med. Chem. Res., 19, S41, (2010). [full text]
  • 70
    ZEYBEK, B., DURMUŞ, Z., TEKİNER-GÜLBAŞ, B., AKI-ŞENER, E., YALÇIN, İ., KILIÇ, E., "Electrochemical Behaviors and Determinations of Some 2,5-Disubstituted Benzoxazole Compounds at the Hanging Mercury Drop Electrode", Current Pharmaceutical Analysis, 5, 21-27, (2009). [full text]
  • 69
    ERTAN, T., YILDIZ, I., TEKINER-GULBAS, B., BOLELLI, K., TEMIZ-ARPACI, O., OZKAN, S., KAYNAK, F., YALCIN, I., AKI, E., “Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents”, European Journal of Medicinal Chemistry, 44, 501–510, (2009). [full text]
  • 68
    ARISOY, M., TEMIZ-ARPACI, O., YILDIZ, I., KAYNAK-ONURDAG, F., AKI, E., YALCIN, I., ABBASOGLU, U., “Synthesis, Antimicrobial Activity and QSAR Studies of 2,5-Disubstituted Benzoxazoles”, SAR and QSAR in Environmental Research, 19(5–6), 589–612, (2008). [full text]
  • 67
    YILDIZ, I., ERTAN, T., BOLELLI, K., TEMIZ-ARPACI, O.,YALCIN, I. AKI, E., "QSAR and Pharmacophore Analysis on Amides against Drug-Resistant S. aureus", SAR and QSAR in Environmental Research, 19(1-2), 101-113, (2008). [full text]
  • 66
    OKSUZOGLU, E., TEKINER-GULBAS, B., ALPER, S., TEMIZ-ARPACI, O., ERTAN, T., YILDIZ, I., DIRIL, N., SENER-AKI, E., YALCIN, I., "Some Benzoxazoles and Benzimidazoles as DNA Topoisomerase I and II Inhibitors", Journal of Enzyme Inhibition and Medicinal Chemistry, 23(1), 37-42, (2008). [full text]
  • 65
    OKSUZOGLU, E., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., EROGLU, H., SEN, G., ALPER, S., YILDIZ, I., DIRIL, N., AKI-SENER, E., YALCIN, I., "A Study on the Genotoxic Activities of Some New Benzoxazoles", Medicinal Chemistry Research, 16, 1–14, (2007). [full text]
  • 64
    TEKINER-GULBAS, B., TEMIZ-ARPACI, O., OKSUZOGLU, E., EROGLU, H., YILDIZ, I., DIRIL, N., AKI-SENER, E., YALCIN, I., "QSAR of Genotoxic Active Benzazoles", SAR and QSAR in Environmental Research, 18(3-4), 251–263, (2007). [full text]
  • 63
    MARTINS, M., SCHELZ, Z., MARTINS, A., MOLNAR, J., HAJÖS, G., RIEDL, Z., VIVEIROS, M., YALCIN, I., AKI-SENER, E., AMARAL, L., "In Vitro and Ex Vivo Activity of Thioridazine Derivatives against Mycobacterium tuberculosis", International Journal of Antimicrobial Agents, 29, 338–340, (2007). [full text]
  • 62
    ERTAN, T., YILDIZ, I., OZKAN, S., TEMIZ-ARPACI, O., KAYNAK, F., YALCIN, I., AKI-SENER, E., ABBASOGLU, U., "Synthesis and Biological Evaluation of New n-(2-Hydroxy-4(or 5)-nitro/ aminophenyl)benzamides and Phenylacetamides as Antimicrobial Agents", Bioorganic and Medicinal Chemistry, 15, 2032-2044, (2007). [full text]
  • 61
    KAROLAK-WOJCIECHOWSKA, J., MROZEK, A., CZYLKOWSKI, R., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., "Five-membered heterocycles. Part IV: Impact of heteroatom on benzazole aromaticity", Journal of Molecular Structure, 839, 125-131, (2007). [full text]
  • 60
    TEMİZ-ARPACI, Ö., TEKINER-GULBAS, B., YILDIZ, İ., AKI-ŞENER, E., YALCIN, İ., "3D-QSAR Analysis on Benzazole Derivatives as Eukaryotic Topoisomerase II Inhibitors by using Comparative Molecular Field Analysis Method", QSAR and Molecular Modelling in Rational Design of Bioactive Molecules, Istanbul-Turkey, September 5-10, 2004, AKI-ŞENER, E., YALÇIN, İ. (Eds.), Başkent Publishing, Ankara, pp.396-398, (2006). [full text]
  • 59
    ALPER-HAYTA, S., AKI-SENER, E., TEKINER-GULBAS, B., YILDIZ, I., TEMIZ-ARPACI, O., YALCIN, I., ALTANLAR, N., “Synthesis, Antimicrobial Activity and QSARs of New Benzoxazine-3-ones”, Eur. J. Med. Chem., 41(12), 1398-1404, (2006). [full text]
  • 58
    TEMIZ-ARPACI, O., COBAN, T., TEKINER-GULBAS, B., CAN-EKE, B., YILDIZ, İ., AKI-SENER, E., YALCIN, I., ISCAN, M., “A Study on the Antioxidant Activities of Some New Benzazole Derivatives”, Acta Biol. Hungarica, 57(2), 201-209, (2006). [full text]
  • 57
    TEKINER-GULBAS, B., TEMIZ-ARPACI, O., YILDIZ, I., AKI-SENER, E., YALCIN, I., “3D-QSAR Study on Heterocyclic Topoisomerase II Inhibitors using CoMSIA”, SAR and QSAR in Enviromental Research, 17(2), 121-132, (2006). [full text]
  • 56
    LAGE, H., AKI-SENER, E., YALCIN, I., “High Antineoplastic Activity of New Heterocyclic Compounds in Cancer Cells with Resistance against Classical DNA Topoisomerase II Targeting Drugs”, Int. J. Cancer, 119, 213-220, (2006). [full text]
  • 55
    VARGA, A., AKI-SENER, E., YALCIN, I., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., CHEREPNEV, G., MOLNAR, J., “Induction of Apoptosis and Necrosis by Resistance Modifiers Benzazoles and Benzoxazines on Tumour Cell Line Mouse Lymphoma L5718 Mdr+cells”, In vivo, 19, 1087-1092, (2005). [full text]
  • 54
    TEMIZ-ARPACI, O., TEKINER-GULBAS, B., YILDIZ, İ., AKI-ŞENER, E., YALÇIN, İ., “3D-QSAR Analysis on Benzazole Derivatives as Eukaryotic Topoisomerase II Inhibitors by using Comparative Molecular Field Analysis Method”, Bioorganic&Medicinal Chemistry, 13, 6354–6359, (2005). [full text]
  • 53
    TEMİZ-ARPACI, O., ÖZDEMİR, A., YALÇIN, İ., YILDIZ, İ., AKI-ŞENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 5-[2-(Morpholin-4-yl)acetamido] and/or 5-[2-(4-Substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl)benzoxazoles", Arch. Pharm. Chem. Life Sci., 338, 105-111, (2005). [full text]
  • 52
    YILDIZ-OREN, İ., TEKINER-GULBAŞ, B., TEMİZ-ARPACI, Ö., YALÇIN, İ., AKI-SENER, E., "Quantitative Structure-Activity Relationships using Comparative Molecular Field Analysis Studies on 2-(p-Substitutedbenzyl)-5-(substituted carbonylamino)benzaoxazoles as Antibacterial Agents against Staphylococcus aureus", Asian Journal of Chemistry, 16(3-4), 1359-1366, (2004). [full text]
  • 51
    ÖREN-YILDIZ, İ., TEKİNER-GULBAŞ, B., YALÇIN, İ., TEMİZ-ARPACI, Ö., AKI-ŞENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of New 2-[p-Substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles”, Arch. Pharm. Pharm. Med. Chem, 337, 402-410, (2004). [full text]
  • 50
    PLEMPER, R.K., ERLANDSON, K.J., LAKDAWALA, A.S., SUN, A., PRUSSIA, A., BOONSOMBAT, J., AKI-ŞENER, E., YALÇIN, İ., YILDIZ, İ., TEMİZ-ARPACI, Ö., TEKİNER, B. P., LIOTTA, D., SNYDER, J.P., COMPANS, R.W., “A Target Site for Template-Based Design of Measles Virus Entry Inhibitors”, PNAS, 101(15), 5628-5633, (2004). [full text]
  • 49
    ÖREN-YILDIZ, İ., YALÇIN, İ., AKI-ŞENER, E., UCARTURK, N., “Synthesis and Structure-Activity Relationships of New Antimicrobial Active Multisubstituted Benzazole Derivatives”, European Journal of Medicinal Chemistry, 39, 291-298, (2004). [full text]
  • 48
    PINAR, A., YURDAKUL, P., YILDIZ, İ., TEMİZ-ARPACI, Ö., AÇAN, N.L., AKI-ŞENER, E., YALÇIN, İ.,”Some Fused Heterocyclic Compounds as Eukaryotic Topoisomerase II Inhibitors”, Biochemical and Biophysical Research Communications, 317, 670-674, (2004). [full text]
  • 47
    YILDIZ-ÖREN, i., AKI-ŞENER, E., ERTAŞ, C., TEMİZ-ARPACI, Ö., YALÇIN, İ., ALTANLAR, N., “Synthesis and Microbiological activity of Some Substituted N-(2-hydroxy-4-nitrophenyl)benzamides and phenylacetamides as Possible Metabolites of Antimicrobial Active Benzoxazoles”, Turk J Chem., 28, 441-449, (2004). [full text]
  • 46
    YALÇIN, İ., TEKİNER, B.P., ÖREN-YILDIZ, İ., TEMİZ-ARPACI, Ö., AKI-ŞENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some Novel 2,6,7-trisubstituted-2H-3,4-dihydro-1,4-benzoxazin-3-one Derivatives”, Indian Journal of Chemistry, 42B, 905-909, (2003). [full text]
  • 45
    AKBAY, A., ÖREN, İ., TEMİZ-ARPACI, Ö., AKI-ŞENER, E., YALÇIN, İ., “Synthesis and HIV-1 Reverse Transcriptase Inhibitor Activity of Some 2,5,6-Substituted Benzoxazole, Benzimidazole, Benzothiazole and Oxazolo(4,5-b)pyridine Derivatives”, Arzneim-Forsch./Drug Res., 53(4), 266-271, (2003). [full text]
  • 44
    AKBAY-YARPUZLU, A., YILDIZ, İ., TEMIZ-ARPACI, Ö., KARAGENÇ, N., AKI-ŞENER, E., YALÇIN, İ., “Adenosine Deaminase Inhibitor Activity of Some Benzoxazole, Benzimidazole, and Oxazolo(4,5-b)pyridine Derivatives”, XIII. Biotecnological Congress Proceedings Book, Çanakkale, 21-26, (2003).
  • 43
    TEMIZ-ARPACI, Ö., OREN, İ., AKI-ŞENER, E., YALÇIN, İ., TEKINER, B., “QSARs of Some Antibacterial Active Benzoxazoles against B. subtilis”, J. Fac. Pharm., Ankara, 31(2), 73-81, (2002). [full text]
  • 42
    OREN, İ., TEMIZ-ARPACI, Ö., YALÇIN, İ., AKI-ŞENER, “QSARs of Some Novel Benzoxazole, Benzimidazole and Oxazolo(4,5-b)pyridine Derivatives against C. albicans”, J. Fac. Pharm. Ankara, 31(1), 21-32, (2002). [full text]
  • 41
    TEMİZ-ARPACI, Ö., AKI-ŞENER, E., YALÇIN, İ., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 2-(p-Substituted-phenyl)benzoxazol-5-yl-arylcarboxamides”, Arch. Pharm. Pharm. Med. Chem, 6, 283-288, (2002). [full text]
  • 40
    TEMİZ-ARPACI, Ö., AKI-ŞENER, E., YALÇIN, İ., ALTANLAR, N., “Synthesis and Microbiological Activity of Some Novel N-[2-(p-Substitutedphenyl)-5-benzoxazolyl]-cyclohexyl carboxamide, -cyclohexyl acetamide and –cyclohexyl propionamide Derivatives”, Il Farmaco, 57, 771-775, (2002). [full text]
  • 39
    AKI-ŞENER, E., BİNGÖL, K.K., TEMİZ-ARPACI, Ö., YALÇIN, İ., ALTANLAR, N., “Synthesis and Microbiological Activity of Some N-(2-hydroxy-4-substitutedphenyl)benzamides, phenylacetamides and furamides as the Possible Metabolites of Antimicrobial Active Benzoxazoles”, Il Farmaco, 57, 451-456, (2002). [full text]
  • 38
    CZYLKOWSKI, R., KAROLAK-WOJCIECHOWSKA, J., MROZEK, A., YALÇIN, İ., ŞENER, E.A., “Spacer Conformation in Biologically Active Molecules. Part I. Structure and Conformational Preferences of 2-Substituted-benzoxazoles”, J. Mol. Structure, 598(2-3), 197-204, (2001). [full text]
  • 37
    AKI-ŞENER, E., BİNGÖL, K.K., ÖREN, İ., TEMİZ-ARPACI, Ö., YALÇIN, İ., ALTANLAR, N., “Synthesis and Microbiological Activity of Some N-(o-hydroxyphenyl)benzamides and phenylacetamides as the Possible Metabolites of Antimicrobial Active Benzoxazoles, Part II.”, Il Farmaco, 55, 469-476, (2000). [full text]
  • 36
    YALÇIN, İ., ÖREN, İ., TEMİZ, Ö., ŞENER, E.A., “QSARs of Some Novel Isosteric Heterocyclics with Antifungal Activity”, Acta Biochimica Polonica, 47(2), 481-486, (2000). [full text]
  • 35
    AKI-ŞENER, E., ARPACI-TEMİZ, Ö., YALÇIN, İ., ALTANLAR, N., “Synthesis and Microbiological Activity of Some Novel 5-Benzamido- and 5-phenylacetamido- substituted 2-phenylbenzoxazole Derivatives”, Il Farmaco, 55, 397-405, (2000). [full text]
  • 34
    MROZEK, A., TRZEZWINSKA, H., KAROLAK-WOICIECHOWSKA, J., YALÇIN, İ., ŞENER, E., “Molecular Structure of 5-Chloro-2-(p-t-butylphenyl)benzoxazole. Relation Between Structure and Antimicrobial Activity of 2,5-Disubstituted Benzoxazoles”, Polish J. Chem., 73, 625-633, (1999). [full text]
  • 33
    MROZEK, A., KAROLAK-WOICIECHOWSKA, J., YALÇIN, İ., ŞENER, E., “Crystal Structure of 2-(2'-Cyclohexyl)ethyl benzimidazole, C15H20N2”, Z. Kristallogr. NCS, 214, 181-182, (1999). [full text]
  • 32
    ÖREN, İ., TEMİZ, Ö., YALÇIN, İ., ŞENER, E., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some Novel 2, 5- and/or 6-Substituted Benzoxazole and Benzimidazole Derivatives”, European Journal of Pharmaceutical Sciences, 7(2), 153-160, (1999). [full text]
  • 31
    TEMİZ, Ö., ÖREN, İ., ŞENER, E., YALÇIN, İ., UÇARTÜRK, N., “Synthesis and Microbiological Activity of Some Novel 5- or 6-Methyl-2-(2,4-disubstituted phenyl)benzoxazole Derivatives”, Il Farmaco, 53, 337-341, (1998). [full text]
  • 30
    YALÇIN, İ., KAYMAKÇIOĞLU, B.K., ÖREN, İ., ŞENER, E., TEMİZ, Ö., AKIN, A., ALTANLAR, N., “Synthesis and Microbiological Activity of Some Novel N-(2-Hydroxyl-5-substitutedphenyl)benzacetamides, Phenoxyacetamides and Thiophenoxyacetamides as The Possible Metabolites of Antimicrobial Active Benzoxazoles”, Il Farmaco, 52(11), 685-689, (1997). [full text]
  • 29
    ÖREN, İ., TEMİZ, Ö., YALÇIN, İ., ŞENER, E., AKIN, A., UÇARTÜRK, N., “Synthesis and Microbiological Activity of 5(or 6)-Methyl-2-substituted Benzoxazole and Benzimidazole Derivatives”, Arzneim-Forsch./Drug Res., 47(II), 1393-1397, (1997). [full text]
  • 28
    ŞENER, E., YALÇIN, İ., TEMİZ, Ö., ÖREN, İ., AKIN, A., UÇARTÜRK, N., "Synthesis and Structure-Activity Relationships of Some 2,5-Disubstitured Benzoxazoles and Benzimidazoles as Antimicrobial Agents", Il Farmaco, 52(2), 99-103, (1997). [full text]
  • 27
    TÜRKER, L., GÜLLÜ, M., YALÇIN, İ., ŞENER, E., ÇELEBİ, N., "Relationships Between Theoretically Calculated LUMO Energies and Cathodic Peak Potentials of Some 2-Benzylbenzoxazole Derivatives", Bulletin Soc Chim. Belg, 105(6), 303-306, (1996). [full text]
  • 26
    ŞENER, E., TEMİZ, Ö., ÖREN, İ., YALÇIN, İ., AKIN, A., UÇARTÜRK, N., "Synthesis, Antibacterial Activity and QSARs of Some 5-Substituted-2-(p-substitutedbenzyl)benzoxazoles using the Free-Wilson Analysis", J. Fac. Pharm. Ankara, 24(1), 10-20, (1995). [full text]
  • 25
    YALÇIN, İ., ŞENER, E., ÖREN, İ., TEMİZ, Ö., "Determination of the Activity Contributions of Some Novel Isosteric Heterocyclics against an Enteric Gram-negative Rod using the Free-Wilson Analysis" In Sans, F., Giraldo, J. and Manaut, F. (Eds.) QSAR and Molecular Modelling:Concepts, Computational Tools and Biological Applications. Prous, Barcelona, pp. 147-151 (1995).
  • 24
    GÜLLÜ, M., YALÇIN, İ., ŞENER, E., TÜRKER, L., ÇELEBİ, N., AKBULUT, U., "Relationships between Cathodic Peak Potentials and Theoretically Calculated LUMO Energies of Some 2-Phenybenzoxazole Derivatives", Bulletin Soc. Chim. Belg, 103(3), 87-90, (1994). [full text]
  • 23
    ŞENER, E., TURGUT, H., YALÇIN, İ., ÖREN, İ., TÜRKER, L., ÇELEBİ, N., AKIN, A., "Synthesis, Microbiological Activity and Structure-Activity Relationships of Some Antimicrobial 5-Substituted-2-(3-pyridyl)benzoxazoles using Quantum Chemical Calculations", International Journal of Pharmaceutics, 110, 109-115, (1994). [full text]
  • 22
    YALÇIN, İ., ŞENER, E., ÖREN, İ., "QSAR of Some Antibacterial Active Isosteric Heterocyclic Compounds against an Enterobacter" In Wermuth, C. G. (Ed.) Trends in QSAR and Molecular Modelling 92. Escom, Leiden, pp. 570-572 (1993).
  • 21
    YALÇIN, İ., ŞENER, E., "QSARs of Some Novel Antibacterial Benzimidazoles, Benzoxazoles and Oxazolopyridines against an Enteric Gram-negative Rod K. pneumoniae", International Journal of Pharmaceutics, 98, 1-8, (1993). [full text]
  • 20
    YALÇIN, İ., ÖREN, İ., ŞENER, E., AKIN, A., UÇARTÜRK, N., "The Synthesis and the Structure- Activity Relationships of Some Substituted Benzoxazoles, Oxazolo(4,5-b)pyridines, benzothiazoles and benzimidazoles as Antimicrobial Agents", European Journal of Medicinal Chemistry, 27, 401-406, (1992). [full text]
  • 19
    ŞENER. E., YALÇIN, İ., SUNGUR, E., "QSAR of Some Antifungal Benzoxazoles and Oxazolo (4,5-b)pyridines against C. albicans", Quantitative Structure-Activity Relationships, 10, 223-228, (1991). [full text]
  • 18
    TÜRKER, L., ŞENER, E., YALÇIN, İ., AKBULUT, U., KAYALIDERE, İ., "QSAR of Some Antifungal Active Benzoxazoles using the Quantum Chemical Parameters", Scientica Pharmaceutica, 58, 107-113, (1990). [full text]
  • 17
    YALÇIN, İ., ŞENER, E., ÖZDEN, T., ÖZDEN, S., AKIN, A., "Synthesis and Microbiological Activity of 5-Metyl-2-(p-substitutedphenyl)benzoxazoles", European Journal of Medicinal Chemistry, 25, 705-708, (1990). [full text]
  • 16
    YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., AKIN, A., YILDIZ, S., "The Antibacterial Activity of 2-Phenyloxazolo(4,5-b)pyridine Derivatives against Gram(-) Bacteria and the Quantitative Structure-Activity Relationships", FABAD J. Pharm. Sci., 13(3), 441-449, (1988). [full text]
  • 15
    ŞENER, E., YALÇIN, İ., AKIN, A., NOYANALPAN, N., "Antifungal Activity of 2-Benzylbenzoxazole Derivatives and QSAR’s by Free-Wilson Analysis", J. Fac. Pharm. Gazi, 4(1), 1-9, (1987). [full text]
  • 14
    ŞENER, E., YALÇIN, İ., ÖZDEN, S., ÖZDEN, T., AKIN, A., YILDIZ, S., "Synthesis and Antimicrobial Activities of 5-Amino-2-(p-substitutedphenyl)benzoxazole Derivativies", Doğa TUJ. Med. and Pharm., 11(3), 391-396, (1987). [full text]
  • 13
    ŞENER, E., YALÇIN, İ., ÖZDEN, S., ÖZDEN, T., AKIN, A., YILDIZ, S., "The Antifungal Activity of 2-(p-Substitutedphenyl)oxazolo(4,5-b)pyridine Derivatives against Candida albicans and the Quantitative Structure-Activity Relationships", FABAD J. Pharm. Sci., 12(4), 281-288, (1987). [full text]
  • 12
    YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., "The Quantitative Structure-Activity Relationships of Antibacterial Active 2-(p-Substitutedphenyl)benzoxazole Derivatives against Gram (+) Bacteria using the Combinations of Some Hydrophobic, Electronic and Steric Paramaters", FABAD J. Pharm. Sci., 12(1), 48-55, (1987). [full text]
  • 11
    YALÇIN, İ., ŞENER, E., ÖZDEN, S., AKIN, A., YILDIZ, S., "The Antibacterial Activity of 2-(p-Substitutedphenyl)oxazolo(4,5-b)pyridine Derivatives against Streptococcus faecalis and Staphylococcus aureus and the Quantitative Structure-Activity Relationships", FABAD j. Pharm. Sci., 12(3), 213-221, (1987). [in Turkish] [full text]
  • 10
    ÖZDEN, S., ÖZDEN, T., ŞENER, E., YALÇIN, İ., AKIN, A., YILDIZ, S., "The Synthesis, Structure Elucidations and Microbiological Activities of 5-Nitro-2-(p-Substitutedphenyl)benzoxazoles-III", FABAD J. Pharm. Sci., 12(1), 39-47, (1987). [in Turkish] [full text]
  • 9
    ŞENER, E., YALÇIN, İ., ÖZDEN, S., ÖZDEN, T., "The Quantitative Structure-Activity Relationships of Antibacterial Active 2-(p-Substitutedphenyl)benzoxazole Derivatives against Gram (-) Bacteria using the Combinations of Some Hydrophobic, Electronic and Steric Paramaters", J. Fac. Pharm. Gazi, 3(2), 133-142, (1986). [full text]
  • 8
    ŞENER, E., YALÇIN, İ., ÖZDEN, S., ÖZDEN, T., "The Quantitative Structure-Activity Relationships of Antifungal Active 2-(p-Substitutedphenyl)benzoxazole Derivatives against Candida albicans using the Combinations of Some Hydrophobic, Electronic and Steric Paramaters", J. Fac. Pharm. Ankara, 16(1), 24-30, (1986) [full text]
  • 7
    YALÇIN, İ., ŞENER, E., ÖZDEN, T., ÖZDEN, S., AKIN, A., YILDIZ, S., "The Synthesis, Structure Elucidations and Microbiological Activities of 5-Chloro-2-(p-Substitutedphenyl)benzoxazoles-II", FABAD J. Pharm. Sci., 11(4), 257-269, (1986). [in Turkish] [full text]
  • 6
    ŞENER, E., ÖZDEN, S., YALÇIN, İ., ÖZDEN, T., AKIN, A., YILDIZ, S., "The Synthesis, Structure Elucidations and Microbiological Activities of 2-(p-Substitutedphenyl)benzoxazoles-I", FABAD J. Pharm. Sci., 11(3), 190-202, (1986). [in Turkish] [full text]
  • 5
    YALÇIN, İ., ŞENER, E., ÖZDEN, T., "The Synthesis and Structure Elucidations of 2-(p-Substitutedphenyl)oxazolo(4,5-b)pyridine Derivatives", J. Fac. Pharm. Ankara, 15(1), 69-78, (1985). [in Turkish] [full text]
  • 4
    ÖZDEN, S., YALÇIN, İ., "Investigations on the Structure-Activity Relationship of 2-Substitutedoxazolo(4,5-b)pyridine Derivatives", J. Fac. Pharm. Ankara, 15(1), 33-42, (1985). [in Turkish] [full text]
  • 3
    ÖZDEN, S., YALÇIN, İ., ÖZDEN, T., "Synthesis and Structure Elucidations of 2-Substitutedoxazolo(4,5-b)pyridine Derivatives", J. Fac. Pharm. Ankara, 14(1), 53-66, (1984). [in Turkish] [full text]
  • 2
    ÖZDEN, S., ÖZDEN, T., YALÇIN, İ., NOYANALPAN, N., "A New Quantitative Determination of Indomethacine by Nuclear Magnetic Resonance Spectroscopy", FABAD J. Pharm. Sci., 8(3), 142-149, (1983). [in Turkish] [full text]
  • 1
    ÖZDEN, T., ÖZDEN, S., YALÇIN, İ., NOYANALPAN, N., "A New Quantitative Determination of Cimetidine by Nuclear Magnetic Resonance Spectroscopy", J. Fac. Pharm. Ankara, 13(1-2), 48-53, (1983). [in Turkish] [full text]

Patents

  • 1
    KIESSIG STEPHAN [DE]; ROCKENSUESS KLAUS-DIETER [DE]; VARGA ANDRAS [DE]; MOLNAR JOSEF [HU]; CHEREPNEV GEORGY [RU]; AKI ESIN [TR]; YALCIN ISMAIL [TR]; LAGE HERMANN [DE]; AMARAL LEONARD [US]; "Composition, useful e.g. for the chemosensibilizing and simultaneous apoptosis induction of multidrug resistance of tumor cells and bacteria, comprises substituted disiloxane compound in combination with benzoxazole derivatives"; DE102008027361; [fulltext] [patent page]

Reviews

  • 7
    ALPER, S., TEMİZ-ARPACI, Ö., AKI-ŞENER, E., YALÇIN, İ.,”Some New bi-and ter-benzimidazole Derivatives as Topoisomerase I Inhibitors”, Il Farmaco, 58, 497-507, (2003). [full text]
  • 6
    YALÇIN, İ., ŞENER, E., "Türkiye İlaç Endüstrisinde Özgün İlaç Etken Maddesi Tasarım ve Geliştirilmesi Çalışmalarının Önem ve Gereksinimi", İlaç ve Kimya Endüstrisi İşverenler Sendikası Yayını, 99-100-101, 4-5, (1996). [in Turkish]
  • 5
    ÖREN, İ., YALÇIN, İ., "Review on the Structure-Activity Relationships of the Chemotherapeutic Active Benzoxazole Derivatives and Their Cyclic Analogs", J. Fac. Pharm. Ankara, 25(2), 81-106, (1996). [in Turkish]
  • 4
    ÖREN, İ., YALÇIN, İ., "A Novel Antibiotic Calcimycine", J. Fac. Pharm. Ankara, 21(1-2), 53-65, (1992). [in Turkish] [full text]
  • 3
    YALÇIN, İ., ŞENER, E., "The Studies on the Searching and Developing of Antiinflammatory, Analgesic and Antipiretic Active Quinazolinon Derivatives", Bulletin of Ankara Chamber of Pharmacists, 8(4), 269-276, (1986). [in Turkish] [full text]
  • 2
    ŞENER, E., YALÇIN, İ., "The Role of Histamine in Inflammation, Activity of the Antiinflammatory Compounds against Histamine", Bulletin of Ankara Chamber of Pharmacists, 8(2),99-110, (1986). [in Turkish] [full text]
  • 1
    YALÇIN, İ., ŞENER, E., "The Structure-Activity Relationships of Selective Antiinflammatory Active Nonacidic Polyaryl Heterocyclic Compounds", FABAD J. Pharm. Sci., 10(3), 183-194, (1985). [in Turkish] [full text]

Oral Presentations

  • 18
    YILDIZ, I., ALPER, S., ERTAN, T., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., AKI-SENER, E., YALCIN, I., "Molecular Modeling Studies on Some Eucaryotic Topoisomerase II Enzyme Inhibitor Fused Heterocyclic Compounds", 6th AFMC International Medicinal Chemistry Symposium, Istanbul-TURKEY, July 08-11, 2007.
  • 17
    PINAR, A., YURDAKUL, P., TEMİZ-ARPACI, O., TEKİNER-GÜLBAŞ, B., YILDIZ, I., AKI-ŞENER, E., YALÇIN, İ., İLERİ, O., “Eukaryotic Topoisomerase II activity of some novel fused heterocyclic compounds”, 31st FEBS Congress, İstanbul, Turkey, 24-29 June 2006.
  • 16
    TEMİZ ARPACI, Ö., ÖKSÜZOĞLU, e., TEKİNER-GÜLBAŞ; B., ZAFER, B., YILDIZ, I., DİRİL, N., AKI-ŞENER, E., YALÇIN, İ., “Genotoxic activities and QSAR studies of some benzoxazoles and benzimidazoles”, QSAR 2006-12th International Workshop on Quantitative Structure-Activity Relationships in Enviromental Toxicology , Lyon, France, Abstract s O -67 , 8-12 May 2006.
  • 15
    AKI-ŞENER, E., YALÇIN, İ., ALPER-HAYTA, S., TEKİNER-GÜLBAŞ; B., TEMİZ ARPACI, Ö., YILDIZ, I., ALTANLAR, N., “Synthesis, antimicrobial activity and QSARs of New Benzoxazine-3-ones”, European Conference on the Reversal of Multidrug Resistance from Bacteria to Cancer Cells and Parasites, Budapest, Hungary, Abstracts OP-10, 22-25 April 2006.
  • 14
    YALÇIN, İ., AKI-ŞENER, E., YILDIZ, I., TEMİZ ARPACI, Ö., TEKİNER-GÜLBAŞ; B., “Research results incorporated on COST B16 Action from the year 2003 to 2006”, European Conference on the Reversal of Multidrug Resistance from Bacteria to Cancer Cells and Parasites, Budapest, Hungary, Abstracts OP-04, 22-25 April 2006.
  • 13
    YILDIZ, I., YALÇIN, İ., AKI-ŞENER, E., TEMİZ ARPACI, Ö., TEKİNER-GÜLBAŞ; B., “3D-QSAR Studies on Some Topoisomerase II Inhibitors” 3rd International Symposium Computational Methods In Toxicology &Pharmacology Integrating Internet Resources (CMTPI-2005), Shanghai, P.R: China, Abstract ORB-06, October 29th- November 1st, 2005.
  • 12
    AKI-ŞENER, E., YALÇIN, İ., YILDIZ, İ., TEMİZ-ARPACI, Ö., ALPER, S., ZAFER, B., “Studies on Pharmacophore Group Identification of Topoisomerase II Inhibitory Active Fused Heterocyclics Using CATALYST HipHop”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya, p19, 13-14 May, 2005.
  • 11
    LAGE, H., AKI-ŞENER, E., YALÇIN, İ., “High Antineoplastic Efficiency of Heterocyclic DNA Topoisomerase II Inhibitors in Classical and Atypical Multidrug-Resistant Cancer Cells”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya, p25, 13-14 May, 2005.
  • 10
    KERBOEUF, D., KOCH, C., GUEGNARD, F., TEKİNER-GULBAS, B., AKI-ŞENER, E., YALÇIN, İ., “Some Fused Heterocyclic Compounds as Anthelmintic against Haemonchus conttortus, Nematode parasite of Ruminants”, The European Cost Action B16 Symposium on Multidrug Resistance Reversal, Antalya, p37, 13-14 May, 2005.
  • 9
    AKI-ŞENER, E., YALÇIN, İ., YILDIZ, I., TEMİZ ARPACI, Ö., ZAFER, B., TEKİNER-GÜLBAŞ; B., ALPER, S., “3D-QSAR Studies of Topoisomerase II Inhibitors Using Catalyst ” Watoc`05, Modelling Structure and Reactivity 7th Congress of the World Association of Theoretically Oriented Chemists, Cape Town, South Africa, Abstract C12-5, 16-21 January 2005.
  • 8
    YALÇIN, İ.; ŞENER, E., ARPACI-TEMİZ, Ö., Tekiner, B. “3-D QSAR of Some Antibacterial Active Heterocyclics Using the CoMSIA Method” 3rd International Symposium on Pharmaceutical Chemistry, Istanbul, Turkey, Abstracts 90, 17-19 September 2001.
  • 7
    ŞENER, E., ÖREN, İ., TEMİZ-ARPACI, Ö., BİNGÖL, K. K., YALÇIN, İ., QSARs of Some Novel Antibacretial Active Isosteric Heterocyclics Against Bacillus Subtilis., 2nd International Symposium on Pharmaceutical Chemistry, Ankara, Turkey, Abstract O-23, 22-24 September 1999.
  • 6
    ŞENER, E., TEMİZ, Ö., ÖREN, İ., YALÇIN, İ., ALTANLAR, N., Synthesis and QSAR Analysis of Some Novel 2,5-Disubstituted Benzoxazoles Against B. subtilis., Second International Meeting on Pharmacy and Pharmaceutical Sciences, İstanbul, Turkey, Abstracts O9, 06-09 September 1998.
  • 5
    ŞENER, E., YALÇIN, İ., SUNGUR, E., Kantitatif Yapı-Etki İlişkileri Analizi Yardımı ile Bir İlaç Etken Madde Tasarım Çalışmaları, Uluslararası Katılımlı I. Eczacılık Bilimleri Sempozyumu, Özet Kitabı S11, 21-23 Haziran 1989.
  • 4
    YALÇIN, İ., ŞENER, E., Ilaç Tasarımında Bilgisayar Uygulamalı Kantitatif Yapı-Etki Ilişkisi Tayini. Antibacteriyal Etkili Benzoksazol Türevlerinin Free-Wilson Analizi, Tıpta Bilgisayar Uygulamaları Sempozyumu II, Izmir, 26-29 Eylül 1988.
  • 3
    ŞENER, E., YALÇIN, İ., SUNGUR, E., Ilaç Tasarımında Bilgisayar Kullanımı. Antifungal Etkili Benzoksazol ve Oksazolo(4,5-b)piridin Türevlerinin Hansch Analizleri Yardımı ile Kantitatif Yapı-Etkileri , Tıpta Bilgisayar Uygulamaları Sempozyum II, Izmir, 26-29 Eylül 1988.
  • 2
    YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., Gram(-) Bakterilere Karşı Antibakteriyel Etkili 2-(p-sübstitüefenil)benzoksazol Türevleri Üzerinde Kantitatif Yapı-Etki IliŞkileri, Kimya ve Kimya Mühendisliği Sempozyumu, Ankara, Özet Kitabı S:69, 17-20 Eylül 1986.
  • 1
    YALÇIN, İ., ŞENER, E., ÖZDEN, S., ÖZDEN, T., Candida albicans’a Karşı Etkili 5-Nitro-2-(p-substitüefenil)benzoksazol Türevlerinin Kantitatif Yapı-Etki Ilişkileri, Kimya ve Kimya Mühendisliği Sempozyumu, Ankara, Özet Kitabı S:68, 17-20 Eylül 1986.

Poster Presentations

  • 20
    BOLELLİ, K., YALCIN, I., ERTAN, T., KAYNAK-ONURDAG, F., YILDIZ, I., TEMIZ-ARPACI, I., AKI-SENER, E., ABBASOGLU, U., "Synhtesis, Structure Elucidation and Microbiological Activity of Some New 2-[4-(4-Substitutedbenzamido)phenyl]benzothiazole Derivatives", Abst. P-61, 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-3), Antalya-TURKEY, October 16-21, 2007.
  • 19
    ARISOY, M., TEMIZ-ARPACI, O., KAYNAK-ONURDAG, F., YILDIZ, I., AKI-SENER, E., YALCIN, I., ABBASOGLU, U., "Synthesis and Antimicrobial Activity of Some Novel 2-(p-Substitutedbenzyl)-5-(2-substitutedacetamido)benzoxazole Derivatives", Abst. P-24, 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (IMMPC-3), Antalya-TURKEY, October 16-21, 2007.
  • 18
    ARISOY, M., TEMIZ-ARPACI, O., KAYNAK-ONURDAG, F., YILDIZ, I., AKI-SENER, E., YALCIN, I., ABBASOGLU, U., "Synthesis and Antimicrobial Activity of Some Novel N-(2-Substitutedbenzoxazol-5-yl)-2-(4-substitutedpiperazin-1-yl)acetamides", Abst. PC-29, 6th AFMC International Medicinal Chemistry Symposium (AIMECS 07), Istanbul-TURKEY, July 08-11, 2007.
  • 17
    YILDIZ, I., AKI-SENER, E., YALCIN, I., TEMIZ-ARPACI, O., TEKINER-GULBAS, B., “3D-QSAR CoMSIA Study on Heterocyclic Topoisomerase II Inhibitors”, The 16th European Symposium on Quantitative Structure-Activity Relationships & Molecular Modelling, Mediterranean Sea, Italy, Abstract page 223, 10-17 September 2006.
  • 16
    ARPACI-TEMİZ Ö., ŞENER, E., YALÇIN, İ.; TEkiner, B., ALTANLAR, N., “Synthesis and Antimicrobial Activity of Some 2,5-Disubstitutedbenzoxazole Derivatives” 3rd International Symposium on Pharmaceutical Sciences, Istanbul, Turkey, Abstracts p. 193, 17-19 September 2001.
  • 15
    ŞENER, E., ÖREN, İ., ARPACI-TEMİZ, Ö., YALÇIN, İ.; “3-D QSAR of Some Antifungal Active Heterocyclic Compounds Using the CoMSIA Method” 13th European Symposium on Quantitative Structure-Activity Relationships, QSAR 2000 Düsseldorf, Germany, Abstracts P 53, 27 August-1 September 2000.
  • 14
    ŞENER, E., ARPACI, Ö. T., ÖREN, İ., BİNGÖL, K. K., YALÇIN, İ., The QSAR Analysis of Some Novel 2-p-Substituted-phenyl-5-Substitutedcarbonylaminobenzoxazoles Against a Gram-Negative Rod., 6th International Symposium on Pharmaceutical Sciences, Ankara, Turkey., Abstracts P-147 p. 282, 27-29 June 2000.
  • 13
    YALÇIN, İ., TEKİNER, B., ÖREN, İ., ŞENER, E., TEMİZ-ARPACI, Ö., ALTANLAR, N., Synthesis and Antimicrobial Activity of Some Novel 2,6,7-Trisubstituted-2(H)-3,4-dihidro-1,4-benzoxazine Derivatives., 2nd International Symposium on Pharmaceutical Chemistry, Ankara, Turkey, Abstract P-09, 22-24 September 1999.
  • 12
    YALÇIN, İ., ÖREN, İ., TEMİZ-ARPACI, Ö., TEKİNER, B., ŞENER, E., QSARs of Some Novel Antifungal Active Isosteric Heterocyclics, 7th International Symposium on Molecular Aspects of Chemotherapy, Gdansk, Poland, Abstracts No 86, p.165, 08-11 September 1999.
  • 11
    ŞENER, E., ÖREN, İ., TEMİZ-ARPACI, Ö., BİNGÖL, K. K., YALÇIN, İ., QSARs of Some Novel Antibacterial Benzoxazoles, Benzimidazoles, Benzothiazoles and Oxazolo(4,5-b)pyridines Against S. aureus., 1999 Gordon Research Conference on Quantitative Structure-Activity Relationships, Tilton, N.H., U.S.A., 25-30 July 1999.
  • 10
    YALÇIN, İ., ŞENER, E., ÖREN, İ., Activity Contributions of Some Novel Isosteric Heterocyclics Against Nosocomial Infection Caused Gram-Negative Rod Using The Free-Wilson Analysis, 1995 Gordon Research Conference on Quantitative Structure-Activity Relationships, Tilton, N.H., U.S.A., 6-11 August 1995.
  • 9
    WOJCIECHOWSKA, J. K., MROZEK, A., YALÇIN, İ., ŞENER, E., Electronic Conditions For Antimicrobial Activity of 2,5-Disubstituted Benzoxazole Derivatives, 5th International Symposium on Molecular Aspects of Chemotherapy, Gdansk, Poland, Abstracts No 4, pg 44, 21-24 August 1995.
  • 8
    WOJCIECHOWSKA, J. K., MROZEK, A., YALÇIN, İ., ŞENER, E., Crystal and Molecular Structure of 5-Chloro-2-(p-ter-buthylphenyl)benzoxazole, 4th International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P113, 27-30 Haziran 1995.
  • 7
    ŞENER, E., YALÇIN, İ., TEMİZ, Ö., ÖREN, İ., BİNGÖL, K. K., AKIN, A., UÇARTÜRK., The Synthesis and Antimicrobiological Activity of Some 2,5-Disubstituted Benzoxazole and Imidazole Derivatives, 4th International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P109, 27-30 Haziran 1995.
  • 6
    ÖREN, İ., YALÇIN, İ., TEMİZ, Ö., ŞENER, E.,Determination of the Activity Contributions of Some Novel Isosteric Heterocyclics Against a Fungi Candida albicans Using The Free-Wilson Analysis, 4th International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P106, 27-30 Haziran 1995.
  • 5
    YALÇIN, İ., ŞENER, E., ÖREN, İ., TEMİZ, Ö., Determination of the Activity Contributions of Some Novel Isosteric Heterocyclics against an Enteric Gram-negative Rod using the Free-Wilson Analysis, 10th European Symposium on Structure-Activity Relationships: QSAR and Molecular Modelling, Barcelona, Spain, Abstracts P-169A, 4-9 Eylül 1994.
  • 4
    ŞENER, E., TEMİZ, Ö., YALÇIN, İ., ÖREN, İ., AKIN, A., UÇARTÜRK, N., The Synthesis and Microbioloical Activity of 5-Substituted-2-(p-substituted benzyl) benzoxazoles Against Staphylococcus aureus, 3rd International Symposium on Pharmaceutical Sciences, Ankara, Abstracts P20, 15-18 Haziran 1993.
  • 3
    ŞENER, E., YALÇIN, İ., TEMIZ, Ö., ÖREN, İ., AKIN, A., The Synthesis and Microbioloical Activity of 5-Substituted-2-(p-substitutedbenzyl)benzoxazoles Against An Enteric Gram-Negative Rod, XIIth International Symposium On Medicinal Chemistry, Basel, Switzerland, Abstracts P-005. B, 13-17 Eylül 1992.
  • 2
    YALÇIN, İ., ŞENER, E., ÖREN, İ., QSARs of Some Antibacterial Active Isosteric Heterosiclic Compounds Against an Enterobacter, 9th European Symposium On Structure-Activity Relationships: QSAR and Molecular Modelling, Strasbourg, France, Abtracts p129, 07-11 Eylül 1992.
  • 1
    YALÇIN, İ., ŞENER, E., ÖREN, İ., AKIN, A., QSARs of Some Antifungal Active Benzoxazoles and Oxazolo(4,5-b)pyridines by Free-Wilson Analysis, 50th International Congress of F.I.P., Istanbul, Abstracts CS181, 03-07 Eylül 1990.

Proceeding Papers

  • 5
    AKI, E., YALCIN, I., YILDIZ, I., TEMIZ-ARPACI, O., BOLELLI, K., ERTAN-BOLELLI, T., DNA-Topoisomerase Inhibitory Activity of Some Heterocyclic Compounds and Their Structure-Activity Relationships", Med. Chem. Res., 19(Suppl.), S6, (2010). [full text]
  • 4
    YALCIN, I., AKI, E., YILDIZ, O., TEMIZ-ARPACI, O., “Antimicrobial Activity and Structure-Activity Relationships of Some Synthesized Benzazoles and Their Possible Metabolites”, Med. Chem. Res. 19 (Suppl. 1), S41, (2010). [full text]
  • 3
    TEMİZ-ARPACI, Ö., TEKINER-GULBAS, B., YILDIZ, İ., AKI-ŞENER, E., YALCIN, İ., "3D-QSAR Analysis on Benzazole Derivatives as Eukaryotic Topoisomerase II Inhibitors by using Comparative Molecular Field Analysis Method", QSAR and Molecular Modelling in Rational Design of Bioactive Molecules, Istanbul-Turkey, September 5-10, 2004, AKI-ŞENER, E., YALÇIN, İ. (Eds.), Başkent Publishing, Ankara, pp.396-398, (2006). [full text]
  • 2
    VARGA, A., AKI-SENER, E., YALCIN, I., B., CHEREPNEV, G., MOLNAR, J., “Induction of Apoptosis and Necrosis by Resistance Modifiers Benzazoles and Benzoxazines on Tumour Cell Line Mouse Lymphoma L5718 MDR+Cells”, Anticancer Research, 24(5D), 3663-3663, (2004). [full text]
  • 1
    AKBAY-YARPUZLU, A., YILDIZ, İ., TEMIZ-ARPACI, Ö., KARAGENÇ, N., AKI-ŞENER, E., YALÇIN, İ., “Adenosine Deaminase Inhibitor Activity of Some Benzoxazole, Benzimidazole, and Oxazolo(4,5-b)pyridine Derivatives”, XIII. Biotecnological Congress Proceedings Book, Çanakkale, 21-26, (2003).